Pediatric Hypomelanosis of Ito Medication

1. Ito M. A singular case of naevus depigmentosus systematicus bilateralis. Jpn J Dermatol. 1951. 61:31-2.

2. Hamada T, Saito T, Sugai T, Morita Y. "Incontinentia pigmenti achromians (Ito)". Arch Dermatol. 1967 Dec. 96(6):673-6. [Medline].

3. Pascual-Castroviejo I, Lopez-Rodriguez L, de la Cruz Medina M, Salamanca-Maesso C, Roche Herrero C. Hypomelanosis of Ito. Neurological complications in 34 cases. Can J Neurol Sci. 1988 May. 15(2):124-9. [Medline].

4. Ruiz-Maldonado R, Toussaint S, Tamayo L, Laterza A, del Castillo V. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol. 1992 Mar. 9(1):1-10. [Medline].

5. Sybert VP. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol. 1994 Nov. 103(5 Suppl):141S-143S. [Medline].

6. Ponti G, Pellacani G, Tomasi A, Percesepe A, Guarneri C, Guerra A, et al. Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report. J Med Case Rep. 2014 Oct 9. 8(1):333. [Medline].

7. Palungwachira P, Palungwachira P. Incontinentia pigmenti achromians of Ito: an ultrastructural study. J Med Assoc Thai. 2006 Feb. 89(2):253-7. [Medline].

8. Parisi L, Di Filippo T, Roccella M. Hypomelanosis of Ito: neurological and psychiatric pictures in developmental age. Minerva Pediatr. 2012 Feb. 64(1):65-70. [Medline].

9. Okanari K, Miyahara H, Itoh M, Takahashi A, Aizaki K, Nakagawa E, et al. Hemimegalencephaly in a Patient With Coexisting Trisomy 21 and Hypomelanosis of Ito. J Child Neurol. 2012 Dec 23. [Medline].

10. Albuja AC, Shrivastava A, Khan GQ. Manifestations of hypomelanosis of Ito. Pediatr Neonatol. 2018 Apr 5. [Medline].

11. Degerliyurt A, Kantar A, Ceylaner S, Aysun S. Hypomelanosis of Ito and Sturge-Weber Syndrome Without Facial Nevus: An Association or a New Syndrome?. Pediatr Neurol. 2009 May. 40(5):395-397. [Medline].

12. Inoue M, Fukuda M, Ishii E, Sayama K. Linear Leukoplakia and Central Nervous System Lesions: A Clinical Clue to the Diagnosis of Hypomelanosis of Ito. J Pediatr. 2015 Sep. 167 (3):771-771.e1. [Medline].

13. Souza PV, Pinto WB, Calente FG, Burlin S, Pedroso JL, Oliveira AS, et al. Hypomelanosis of Ito presenting with adult-onset dementia and marked enlarged Virchow-Robin spaces. Arq Neuropsiquiatr. 2015 Apr. 73 (4):366-8. [Medline].

14. Glover MT, Brett EM, Atherton DJ. Hypomelanosis of Ito: spectrum of the disease. J Pediatr. 1989 Jul. 115(1):75-80. [Medline].

15. Pascual-Castroviejo I, Roche C, Martinez-Bermejo A, et al. Hypomelanosis of ITO. A study of 76 infantile cases. Brain Dev. 1998 Jan. 20(1):36-43. [Medline].

16. Park JM, Kim HJ, Kim T, Chae HW, Kim DH, Lee MG. Sexual precocity in hypomelanosis of Ito: mosaicism-associated case report and literature review. Int J Dermatol. 2011 Feb. 50(2):168-74. [Medline].

17. Pavone V, Signorelli SS, Praticò AD, Corsello G, Savasta S, Falsaperla R, et al. Total Hemi-overgrowth in Pigmentary Mosaicism of the (Hypomelanosis of) Ito Type: Eight Case Reports. Medicine (Baltimore). 2016 Mar. 95 (10):e2705. [Medline].

18. Gatter N, Hoppe B, Nutzenadel F, Waldherr R, Querfeld U. A cutaneous disease with multisystem involvement: hypomelanosis of Ito may be associated with proteinuria, focal segmental glomerulosclerosis and end-stage renal disease. Nephrol Dial Transplant. 2007 Mar 8. [Medline].

19. Tragardh M, Thomsen CR, Thorninger R, Moller-Madsen B. Hypomelanosis of Ito presenting with pediatric orthopedic issues: a case report. J Med Case Rep. 2014 May 19. 8:156. [Medline]. [Full Text].

20. Jozwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol. 2000 Oct. 15(10):652-9. [Medline].

21. Sybert VP, Pagon RA, Donlan M, Bradley CM. Pigmentary abnormalities and mosaicism for chromosomal aberration: association with clinical features similar to hypomelanosis of Ito. J Pediatr. 1990 Apr. 116(4):581-6. [Medline].

22. Ullah F, Schwartz RA. Nevus depigmentosus: review of a mark of distinction. Int J Dermatol. 2019 Feb 22. [Medline].

23. Yamamoto T, Hirano M, Ueda K. Eccrine Angiomatous Hamartoma in a Patient with Nevus Depigmentosus and Nevus Spilus. Indian J Dermatol. 2017 Jan-Feb. 62 (1):99-100. [Medline].

24. Rosman NP. Incontinentia Pigmenti. Gomez MR, ed. Neurocutaneous Diseases: A Practical Approach. Boston: Butterworths; 1987. 294-300.

25. Zieleniewski Ł, Schwartz RA, Goldberg DJ, Handler MZ. Voigt-Futcher pigmentary demarcation lines. J Cosmet Dermatol. 2019 Jun. 18 (3):700-702. [Medline].

26. Huggins RH, Schwartz RA, Janniger CK. Vitiligo. Acta Dermatovenerol Alp Panonica Adriat. 2005 Dec. 14(4):137-42, 144-5. [Medline].

27. Huggins RH, Janusz CA, Schwartz RA. Vitiligo: a sign of systemic disease. Indian J Dermatol Venereol Leprol. 2006 Jan-Feb. 72(1):68-71. [Medline].

28. Jadotte YT, Janniger CK. Pityriasis alba revisited: perspectives on an enigmatic disorder of childhood. Cutis. 2011 Feb. 87(2):66-72. [Medline].

29. Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc. 2008 Apr. 13(1):20-4. [Medline].

30. Urban J, Toruniowa B, Janniger CK, Czelej D, Schwartz RA. Incontinentia pigmenti (Bloch-Sulzberger syndrome): multisystem disease observed in two generations. Cutis. 1996 Nov. 58(5):329-36. [Medline].

Camila K Janniger, MD Clinical Professor of Dermatology, Clinical Associate Professor of Pediatrics, Chief of Pediatric Dermatology, Rutgers New Jersey Medical School

Camila K Janniger, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Marcio Sotero de Menezes, MD Clinical Associate Professor, Department of Neurology, Division of Pediatric Neurology, Seattle Children's Hospital, University of Washington School of Medicine; Director, Pediatric Neuroscience Center and Genetic Epilepsy Clinic, Swedish Neuroscience Institute

Marcio Sotero de Menezes, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society

Disclosure: Received salary from Novartis for speaking and teaching; Received salary from Cyberonics for speaking and teaching; Received salary from Athena diagnostics for speaking and teaching.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, Rutgers New Jersey Medical School; Visiting Professor, Rutgers University School of Public Affairs and Administration

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, New York Academy of Medicine, American Academy of Dermatology, American College of Physicians, Sigma Xi

Disclosure: Nothing to disclose.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Kevin P Connelly, DO Clinical Assistant Professor, Department of Pediatrics, Division of General Pediatrics and Emergency Care, Virginia Commonwealth University School of Medicine; Medical Director, Paws for Health Pet Visitation Program of the Richmond SPCA; Pediatric Emergency Physician, Emergency Consultants Inc, Chippenham Medical Center

Kevin P Connelly, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Osteopathic Pediatricians, American Osteopathic Association

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article